ESC 365 - Controversies in heart failure - Introduction to the session

ESC Premium Access

Controversies in heart failure - Introduction to the session

Session: Controversies in heart failure

Topic: Pathophysiology and diagnosis

Speaker: Doctor C. Yancy (Chicago, US)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Clyde Yancy

Northwestern University, Chicago (United States of America)

9 presentations

0 follower

5 more presentations in this session

ACE - inhibitors should be replaced by LCZ696 as first line therapy for heart failure - PRO

Speaker: Professor J. McMurray (Glasgow, GB)

ACE - inhibitors should be replaced by LCZ696 as first line therapy for heart failure - CON

Speaker: Professor G. Rosano (London, GB)

B-Blockers and digoxin should be forgotten in atrial fibrillation heart failure - PRO

Speaker: Professor S. Hohnloser (Frankfurt, DE)

B-Blockers and digoxin should be forgotten in atrial fibrillation heart failure - CON

Speaker: Professor J. Bauersachs (Hannover, DE)

Controversies in heart failure - Conclusion

Speaker: Professor S. Anker (Berlin, DE)

Access the full session

Controversies in heart failure

Speakers: Doctor C. Yancy, Professor J. McMurray, Professor G. Rosano, Professor S. Hohnloser, Professor J. Bauersachs...

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources